Short answer
ROCKET PHARMACEUTICALS, INC. (RCKT) filed an 8-K current report with the SEC on May 21, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 80,774,659 shares represented, equal to approximately 74.02% of eligible voting shares.
ROCKET PHARMACEUTICALS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 80,774,659 shares represented, equal to approximately 74.02% of eligible voting shares
- All seven director nominees elected, including David P. Southwell with 43,172,112 votes for and 20,112,032 withheld
- EisnerAmper LLP appointment ratified for fiscal year ending December 31, 2026, with 79,195,009 votes for
- Executive compensation approved in advisory vote, with 61,389,376 votes for
- Stock option exchange program approved, with 45,582,445 votes for versus 17,615,213 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ROCKET PHARMACEUTICALS, INC. 8-K filings
Get the next RCKT 8-K as it lands
Follow RCKT for push alerts, or ask the research agent what this filing means.